Nexalin Technology Inc asset turnover ratio, the ability of Nexalin Technology Inc 's assets to generate revenue in the third quarter 2026, increased sequentially to 0.08 in the third quarter (Sep 30 2026), NXL's balance sheet remain strong.

Within sector 170 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2026 compared to the preceding quarter from 2729 to 3378.

Asset Turnover Ratio Definition

Select the Comparisons :

None ▼

Select the Ratio:

Asset Turnover▼

None ▼

Asset Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NXL Asset Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Asset Change	-33.61 %	-54.23 %	27.39 %	9.75 %	-4.33 %
Y / Y Revenue Change	331.43 %	-82.77 %	-63.55 %	532.46 %	-49.63 %
Asset Turnover Ratio (TTM)	0.08	0.05	0.06	0.06	0.03
NXL's Total Ranking	# 3378	# 2729	# 2959	# 3121	#
Seq. Asset Change	13.28 %	-18.69 %	-20.29 %	-9.57 %	-21.91 %
Seq. Revenue Change	543.87 %	-18.66 %	-91.3 %	847.13 %	-74.29 %

Asset Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 171
Healthcare Sector	# 506
Overall Market	# 3378

Asset Turnover Ratio Statistics
High	Average	Low
0.18	0.06	0.02
(Mar 31 2023)		(Sep 30 2023)

NXL Company Profile • Back to NXL Efficiency Comparisons • Compare NXL Asset Turnover Ratio to its Competitors

Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Asset Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Assets at quarter ending Sep 30 2026
Abeona Therapeutics Inc	0.22	$ 41.912 Millions	$ 192.374 Millions
Atara Biotherapeutics Inc	0.20	$ 4.019 Millions	$ 19.966 Millions
Teleflex Incorporated	0.19	$ 1,283.675 Millions	$ 6,716.220 Millions
Elutia Inc	0.18	$ 9.637 Millions	$ 52.350 Millions
Maxcyte inc	0.18	$ 34.374 Millions	$ 191.034 Millions
Septerna Inc	0.16	$ 96.268 Millions	$ 588.004 Millions
Lexicon Pharmaceuticals Inc	0.16	$ 38.537 Millions	$ 236.472 Millions
Wave Life Sciences Ltd	0.15	$ 87.296 Millions	$ 572.074 Millions
Omniab Inc	0.14	$ 40.211 Millions	$ 293.935 Millions
Standard Biotools Inc	0.14	$ 83.592 Millions	$ 617.355 Millions
Ligand Pharmaceuticals Incorporated	0.14	$ 253.827 Millions	$ 1,879.020 Millions
Bicycle Therapeutics Plc	0.13	$ 83.528 Millions	$ 635.938 Millions
Kura Oncology Inc	0.12	$ 79.314 Millions	$ 636.301 Millions
Voyager Therapeutics Inc	0.12	$ 25.108 Millions	$ 211.603 Millions
Monte Rosa Therapeutics Inc	0.11	$ 70.325 Millions	$ 643.493 Millions
Beam Therapeutics Inc	0.10	$ 146.644 Millions	$ 1,404.350 Millions
Opus Genetics Inc	0.10	$ 7.914 Millions	$ 76.323 Millions
Coya Therapeutics Inc	0.10	$ 4.689 Millions	$ 47.462 Millions
Ocular Therapeutix Inc	0.07	$ 50.384 Millions	$ 704.388 Millions
Stoke Therapeutics Inc	0.07	$ 28.211 Millions	$ 415.592 Millions
Intellia Therapeutics Inc	0.06	$ 52.887 Millions	$ 840.157 Millions
Stablecoin Development Corporation	0.06	$ 7.246 Millions	$ 126.127 Millions
Seer Inc	0.05	$ 14.248 Millions	$ 266.663 Millions
Recursion Pharmaceuticals Inc	0.05	$ 68.232 Millions	$ 1,312.008 Millions
Abcellera Biologics Inc	0.05	$ 67.858 Millions	$ 1,367.875 Millions
Lenz Therapeutics Inc	0.05	$ 12.359 Millions	$ 256.189 Millions
Co diagnostics Inc	0.05	$ 0.859 Millions	$ 18.906 Millions
Cytomx Therapeutics Inc	0.04	$ 14.027 Millions	$ 314.207 Millions
Metagenomi Therapeutics Inc	0.04	$ 7.086 Millions	$ 187.286 Millions
Aclaris Therapeutics Inc	0.03	$ 6.401 Millions	$ 188.758 Millions

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.